Caredx earnings were $128.6M for the trailing 12 months ending Sep 30, 2026, with 84.4% growth year over year. The latest CDNA earnings report on Sep 30, 2026 announced Q3 2026 earnings of $19.3M, down 82.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CDNA reported annual earnings of -$21.4M, with -140.6% growth.
CDNA past earnings growth
How has CDNA's earnings growth performed historically?
On CDNA's earnings call on Oct 29, 2026, Caredx (NASDAQ: CDNA) reported Q3 2026 earnings per share (EPS) of $0.37, up 1,133.33% year over year. Total CDNA earnings for the quarter were $19.29 million. In the same quarter last year, Caredx's earnings per share (EPS) was $0.03.
As of the last Caredx earnings report, Caredx is currently profitable. Caredx's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $128.63 million, a 82.58% increase year over year.
What was CDNA's earnings growth in the past year?
As of Caredx's earnings date in Oct 29, 2026, Caredx's earnings has grown 84.44% year over year. This is 72.99 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 11.46%. CDNA earnings in the past year totalled $128.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.